Why is this still at .03? Hope? Pandora box?
On June 23, 2014, the Company received the resignations of Dr. David Berkoff, Rick Harris, JoAnne Brandes, Jeanne Hebert and Neil Chin. None of the resignations received are due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company continues to seek strategic alternatives in order to continue operations. If the Company is unable to secure a transaction or find significant, additional sources of capital, it will be forced to discontinue operations in the next 30 days.
===================================================
FUSE SCIENCE, INC. - 8-K (Filed: 25-06-2014)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) June 25, 2014
FUSE SCIENCE, INC.
(Exact Name of Registrant as Specified in Charter)
Nevada
(State or Other Jurisdiction
of Incorporation)
000-22991 87-0460247
(Commission
File Number) (IRS Employer
Identification No.)
6135 NW 167 th Street, #E-21
Miami Lakes, Florida 33015
(Address of Principal Executive Offices) (Zip Code)
(305) 503-3873
(Registrant’s telephone number, Including Area Code)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 23, 2014, the Company received the resignations of Dr. David Berkoff, Rick Harris, JoAnne Brandes, Jeanne Hebert and Neil Chin. None of the resignations received are due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company continues to seek strategic alternatives in order to continue operations. If the Company is unable to secure a transaction or find significant, additional sources of capital, it will be forced to discontinue operations in the next 30 days.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
FUSE SCIENCE, INC.
By: /s/ Brian Tuffin
Brian Tuffin, Chief Executive Officer and Acting Chief Financial Officer
Dated: June 25, 2014 |
